article · Immunopharmacology and Immunotoxicology
BACKGROUND: The increasing use of silica nanoparticles (SiNPs) has raised concerns about their hazards to human health. However, immunotoxic effect remains insufficiently explored. OBJECTIVE: To assess: the immunotoxicity of orally administered SiNPs; role of inflammation, apoptosis, autophagy; and the protective role of vitamin C. METHODS: Eighty Sprague Dawley rats were randomly divided into four groups: control, SiNPs, vitamin C, and combined SiNPs + vitamin C. SiNPs and vitamin C were orally administered for 90 days. Immunotoxicity was assessed using flow cytometry for lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, CD16+, CD56+), cytokine assays for IL-1β, IL-6, and IFN-γ, histopathological evaluation of bone marrow, and immunohistochemistry for Caspase-3 (apoptosis) and Beclin-1 (autophagy). RESULTS: SiNPs exposure caused significant elevations in CD3+, CD4+, CD8+, CD16+, and CD19+ cells and a reduction in CD56+ cells. Serum cytokine levels increased markedly in the SiNPs group than controls (107.7 ± 13.7 pg/mL, 22.9 ± 6.7 pg/mL, 13.5 ± 1.6 pg/mL vs. 53.5 ± 6.5 pg/mL, 9.38 ± 1.6 pg/mL, 6.7 ± 0.8 pg/mL respectively) showing a 2.01-fold rise in IL-1β and IFN-γ and a 2.44-fold rise in IL-6. Co-administration of vitamin C attenuated these increases, reducing IL-1β, IL-6, and IFN-γ by 0.63-, 0.56-, and 0.62-fold compared with SiNPs alone. Bone marrow showed decreased cellularity after SiNPs exposure, which vitamin C partially reversed. Caspase-3 expression was upregulated, while Beclin-1 was downregulated following SiNPs exposure, both ameliorated by vitamin C. CONCLUSION: SiNPs induce immune dysfunction through inflammation, apoptosis, and autophagy inhibition. Vitamin C administration significantly counteracts these effects.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1080/08923973.2025.2585084
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.